September 16, 2008 - National Instruments has selected the Visica 2 Treatment System as the Humanitarian Application of the Year at the first-ever Graphical System Design Achievement Awards held recently as part of the NIWeek conference in Austin, TX.

The Visica System is a minimally invasive cryotechnology device cleared for market by the Food and Drug Administration (FDA) for the treatment of fibroadenomas, a common benign breast condition found in at least 10 percent of all women in the U.S. The procedure uses cryoablation, or extreme cold, to destroy tumors without requiring stitches or general anesthesia. The office-based procedure, which usually takes less than 30 minutes, involves placing a small needle into the center of the tumor using ultrasound guidance. The System creates very cold temperatures at the needle tip, freezing the fibroadenoma, damaging the tumor cells and causing them to break down to prevent re-growth.

Visica 2 provides women with a treatment option for their fibroadenomas that safely and effectively treats the lump in their breast. The Visica 2 Treatment System uses liquid nitrogen as the freezing agent, obviating the need for large, high-pressure tanks of argon and helium used in the original Visica Treatment System. Because nitrogen operates at colder temperatures than argon, it reportedly allows for a more efficient, faster treatment. The procedure can be completed in the physician's office, with most treatment times under 30 minutes.

More than 110 authors from 13 countries submitted papers for the Graphical System Design Achievement Awards. A judging committee of more than 30 technical publication editors and NI experts judged papers submitted across 10 application categories.

For more information: www.sanarus.com


Related Content

News | Breast Imaging

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior ...

Time July 09, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
Subscribe Now